Understanding Challenges and Needs in Refractory Chronic GVHD

Insights from 2023 ASH Annual Meeting
J

Clonal Hematopoiesis Is Common in Unrelated Stem Cell Donors but Has No Impact on Pt Outcome After SCT

By Insights from 2023 ASH Annual Meeting FEATURING Johannes Schetelig
By Insights from 2023 ASH Annual Meeting FEATURING Johannes Schetelig
52 views
December 29, 2023
Comments 0
Login to view comments. Click here to Login
06:18

CSF1R's Role in Modulating Inflammation and Fibrosis in cGVHD

Robert Zeiser

51 views
23:37

Management of Viral Infections Post-Transplant: CMV, EBV, and HHV-6

Rush University Medical Center

E. Bhaimia

333 views
07:22

Steroid-Refractory GvHD Management: When to Switch From Steroids

Giuseppe Francesco Milone

74 views
46:03

CAR NK Cells: Next Generation Cell Therapies for Cancer

University of Colorado Cancer Center

K. Rezvani

271 views
08:08

Unmet Needs in GvHD and the Role of Axatilimab

Jose Perez Simon

75 views
08:43

Maintaining QoL in Chronic GvHD

Nandita Khera

50 views
17:18

Approaches to Preventing and Treating GVHD in 2024

Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

N. Hossain

137 views
14:19

Axatilimab in Chronic GVHD: Updates From the AGAVE-201 Study

Zachariah DeFilipp

179 views
27:21

Updates in Transplantation and GVHD From Recent Meetings

UChicago Medicine

M. Nawas

52 views
31:53

HSCT in 2024: What Every Hematologist Needs to Know

Indy Hematology Review

R. Childs

740 views
10:54

Chronic GVHD: Results from Agave-201 - Axatilimab at 3 Different Dos…

Insights from 2023 ASH Annual Meeting

D. Wolff

94 views